Rod-Cone Dystrophy: Clinical Trials

2 trials for Rod-Cone Dystrophy, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 recruiting. 1 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 11Recruiting 1
Phase 21Recruiting 1

Follow Rod-Cone Dystrophy: new trials by email Literature Review of Rod-Cone Dystrophy trials Research Report on Rod-Cone Dystrophy

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study to Investigate the Safety of OpCT-001 in Adults Who Have Primary Photoreceptor Disease (CLARICO)
OpCT-001 - Primary Photoreceptor Disease, Retinitis Pigmentosa (RP)
Phase 1 / Phase 2RecruitingBlueRock Therapeutics542025-03-102026-10-15
Inherited Retinal Degenerative Disease Registry
Eye Diseases Hereditary, Retinal Disease
RecruitingFoundation Fighting Blindness200002014-06-012026-05-19

Narrower conditions

Cone-Rod Dystrophies (2)  ·  Retinitis Pigmentosa (2)  ·  Usher Syndromes (2)  ·  Abetalipoproteinemia (1)  ·  Achromatopsia 3 (1)  ·  Bardet-Biedl Syndrome (1)  ·  Charcot-Marie-Tooth Disease (1)  ·  Choroideremia (1)  ·  Color Vision Defects (1)  ·  Cone Dystrophy (1)  ·  Enhanced S-Cone Syndrome (1)  ·  Eye Diseases, Hereditary (1)  ·  Fundus Albipunctatus (1)  ·  Gyrate Atrophy (1)  ·  Kearns-Sayre Syndrome (1)

Broader conditions

Abnormalities, Multiple (2)  ·  Blindness (2)  ·  Congenital Abnormalities (2)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (2)  ·  Deaf-Blind Disorders (2)  ·  Deafness (2)  ·  Ear Diseases (2)  ·  Eye Diseases (2)  ·  Genetic Diseases, Inborn (2)  ·  Hearing Disorders (2)  ·  Hearing Loss (2)  ·  Hearing Loss, Sensorineural (2)  ·  Nervous System Diseases (2)  ·  Neurologic Manifestations (2)  ·  Otorhinolaryngologic Diseases (2)

Sponsors

BlueRock Therapeutics (1)  ·  Foundation Fighting Blindness (1)

Countries

United States (2)

Top investigators

Todd Durham, PhD (1)